Document Detail


Development of fluorescent labeling methods for stem cells.
MedLine Citation:
PMID:  22465918     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
For successful development of cell-based therapy, both the disposition and differentiation of transplanted cells are directly related to therapeutic effects. In vivo imaging is an attractive tool to obtain real-time information on the disposition of target cells. In various types of imaging methods such as positron emission tomography(PET) and magnetic resonance imaging(MRI), fluorescence imaging is suitable for visualizing the disposition of cells because it can visualize single cells both in vitro and in vivo. For the trafficking of stem cells after transplantation, it is necessary to label living cells for long time periods without disturbing the function or differentiation of the labeled cells. Recently, we have developed quantum dots modified with polyamidoamine(PAMAM) dendrimers. These can more rapidly escape from endosomes and sustain their fluorescence intensity compared with unmodified quantum dots in primary cultured mesenchymal stem cells (MSCs). Fluorescence intensity was also sustained after intravenous injection of MSCs labeled with PAMAM dendrimer-modified quantum dots. To study the dynamics of MSCs in vivo, we constructed a piggyBack transposon vector that can integrate the target gene into the genome in mammalian cells, and established primary MSCs with long-term expression of EmGFP. In addition, we also developed a suction device stabilizing tissue for in vivo real time imaging. In this section, I present our recent findings on long-term fluorescent labeling of MSCs and in vivo visualizing of cell dynamics in a living mouse.
Authors:
Yuriko Higuchi
Related Documents :
21176958 - Therapeutic efficacy of focal adhesion kinase downregulation in reh cells by rna interf...
7453818 - A protein called immaturin controlling sexual immaturity in paramecium.
12751958 - Cell cycle-dependent expression of phosphorylated histone h2ax: reduced expression in u...
22405128 - Magnetic enhancement of cell retention, engraftment and functional benefit after intrac...
23943428 - Sialoglycoproteins in morphological distinct stages of mucor polymorphosporus and their...
2714338 - Characterization of cisplatin-resistant colo 316 human ovarian carcinoma cells.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan     Volume:  132     ISSN:  1347-5231     ISO Abbreviation:  Yakugaku Zasshi     Publication Date:  2012  
Date Detail:
Created Date:  2012-04-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0413613     Medline TA:  Yakugaku Zasshi     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  433-9     Citation Subset:  IM    
Affiliation:
Graduate School of Pharmaceutical Sciences, Kyoto University.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In Vivo Imaging Reveals Adipose Tissue Inflammation in Obesity and Multi-cellular Processes of Devel...
Next Document:  Methylarginies-induced Endothelial Dysfunction in Chronic Kidney Disease.